Innovative Eyewear Toekomstige groei
Future criteriumcontroles 2/6
Innovative Eyewear is forecast to grow revenue at 142.5% per annum.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
| Medical Equipment winstgroei | 17.4% |
| Inkomstengroei | 142.5% |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 13 Aug 2024 |
Recente toekomstige groei-updates
Geen updates
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2025 | 14 | N/A | N/A | N/A | 1 |
| 12/31/2024 | 3 | N/A | N/A | N/A | 1 |
| 6/30/2024 | 2 | -8 | -6 | -6 | N/A |
| 3/31/2024 | 1 | -7 | -6 | -6 | N/A |
| 12/31/2023 | 1 | -7 | -6 | -6 | N/A |
| 9/30/2023 | 1 | -6 | -6 | -6 | N/A |
| 6/30/2023 | 1 | -6 | -5 | -5 | N/A |
| 3/31/2023 | 1 | -6 | -4 | -4 | N/A |
| 12/31/2022 | 1 | -6 | -3 | -3 | N/A |
| 9/30/2022 | 1 | -5 | -3 | -3 | N/A |
| 6/30/2022 | 1 | -5 | -2 | -2 | N/A |
| 3/31/2022 | 1 | -4 | -2 | -2 | N/A |
| 12/31/2021 | 1 | -3 | -1 | -1 | N/A |
| 9/30/2021 | 0 | -2 | -1 | -1 | N/A |
| 6/30/2021 | 0 | -1 | 0 | 0 | N/A |
| 3/31/2021 | 0 | -1 | 0 | 0 | N/A |
| 12/31/2020 | 0 | -1 | 0 | 0 | N/A |
| 12/31/2019 | 0 | 0 | N/A | N/A | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if LUCY's forecast earnings growth is above the savings rate (2.5%).
Winst versus markt: Insufficient data to determine if LUCY's earnings are forecast to grow faster than the US market
Hoge groeiwinsten: Insufficient data to determine if LUCY's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: LUCY's revenue (142.5% per year) is forecast to grow faster than the US market (8.9% per year).
Hoge groei-inkomsten: LUCY's revenue (142.5% per year) is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if LUCY's Return on Equity is forecast to be high in 3 years time